COLOCROSS
Phase 3 Completed
89 enrolled
ACE
Phase 2 Completed
170 enrolled
REPROGRAM-01
Phase 2 Completed
49 enrolled
CB-839 + Capecitabine in Solid Tumors and Fluoropyrimidine Resistant PIK3CA Mutant Colorectal Cancer
Phase 1/2 Completed
50 enrolled 16 charts
AVANA
Phase 2 Completed
101 enrolled
AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)
Phase 1 Completed
50 enrolled
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
460 enrolled
Combination Chemotherapy and Cetuximab as First-Line Therapy in Treating Patients With Advanced and/or Metastatic Colorectal Cancer
Phase 2 Completed
169 enrolled
Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer
Phase 1/2 Completed
42 enrolled 16 charts
Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Phase 2 Completed
60 enrolled
Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
145 enrolled
SorCape
Phase 2 Completed
43 enrolled 12 charts
Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal Cancer
Phase 1/2 Completed
Irinotecan and Capecitabine in Treating Patients With Solid Tumors
Phase 1 Completed
30 enrolled
Combination Chemotherapy After Surgery in Treating Patients With High-Risk Stage II or Stage III Colorectal Cancer
Phase 3 Completed
6,088 enrolled
Study of Perifosine + Capecitabine for Colon Cancer Patients
Phase 1 Completed
10 enrolled
Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients
Phase 2 Completed
381 enrolled
Safety of Xeloda in Solid Tumours
Completed
1,268 enrolled
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer
Phase 1 Completed
51 enrolled
Capecitabine and Irinotecan in Treating Patients With Locally Advanced, Recurrent, or Metastatic Colorectal Cancer
Phase 2 Completed
67 enrolled 15 charts
Neoadjuvant Treatment of Colon Cancer
Phase 2 Completed
76 enrolled
Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel Cancer
Phase 1 Completed
RO4929097 and Capecitabine in Treating Patients With Refractory Solid Tumors
Phase 1 Completed
30 enrolled
Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
Phase 2 Completed
50 enrolled 12 charts
NGR-hTNF Administered in Combination With a Standard Oxaliplatin Based Regimen in Patients With Metastatic Colorectal Cancer
Phase 2 Completed
24 enrolled
Capecitabine and Gemcitabine in Patients With Metastatic Colorectal Cancer
Phase 2 Completed
53 enrolled
Study of Xeloda and Gleevec in Patients With Advanced Solid Tumors
Phase 1 Completed
40 enrolled
Oxaliplatin and Bevacizumab (Avastinâ„¢) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal Cancer
Phase 3 Completed
Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver
Phase 2 Completed
75 enrolled
Capecitabine, Cetuximab, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
30 enrolled 10 charts
Celecoxib, Capecitabine, and Irinotecan in Treating Patients With Recurrent or Metastatic Colorectal Cancer
Phase 2 Completed
GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors
Phase 1 Completed
20 enrolled
S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically Removed
Phase 2 Completed
29 enrolled
Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal Cancer
Phase 3 Completed
86 enrolled
Oxaliplatin, Irinotecan, and Capecitabine in Treating Patients With Advanced or Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 1/2 Completed
23 enrolled
Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
Phase 2 Completed
74 enrolled